Travere Therapeutics, Inc. Common Stock (TVTX) is a publicly traded Healthcare sector company. As of August 25, 2026, TVTX trades at $67.10 with a market cap of $6.15B and a P/E ratio of -228.97. TVTX moved +2.88% today. Year to date, TVTX is +70.69%; over the trailing twelve months it is +263.95%. Its 52-week range spans $12.91 to $66.38. Analyst consensus is strong buy with an average price target of $74.67. Rallies surfaces TVTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest TVTX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $67.10 |
| Market Cap | $6.15B |
| P/E Ratio | -228.97 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $66.38 |
| 52-Week Low | $12.91 |
| Volume | 863.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $490.73M |
| Net Income | $-25.55M |
| Gross Margin | 97.89% |
12 analysts cover TVTX: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $74.67.